Frontlight ResearchEarly access
Trial site
Abington Neurological Associates, Ltd
- 3running trials
- 6closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease7 trials
- Narcolepsy2 trials
- Frontotemporal dementia1 trial
- Lewy body dementia1 trial
- Phase
- Phase 24 trials
- Phase 34 trials
- Phase 42 trials
- Status
- Completed4 trials
- Active, not recruiting3 trials
- Suspended1 trial
- Terminated1 trial
- Withdrawn1 trial
- Lead sponsor
- Eli Lilly and Company3 trials
- Jazz Pharmaceuticals2 trials
- ACADIA Pharmaceuticals Inc.1 trial
- Biogen1 trial
- Eisai Inc.1 trial
- and 2 more
Running trials
Active, not recruiting
A Study of E2814 With Concurrent Lecanemab Treatment in Participants With Early Alzheimer's Disease
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Active, not recruiting
Closed trials
Recruiting
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
Completed
Completed
Terminated
A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease
Completed
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026